Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. I. Study design, procedures, and management

Journal of Periodontology

Volumn 68, Issue 2, 1997, Pages 110-118

  Polson, Alan M ^a,b   Garrett, Steven ^b,c   Stoller, Norman H ^d   Bandt, Carl L ^e   Hanes, Philip J ^f   Killoy, William J ^g   Harrold, Charles Q ^d   Southard, G Lee ^b   Duke, Susan P ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b QLT Inc   (United States)

^c LOMA LINDA UNIVERSITY   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

^g UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

clinical trials; doxycycline therapeutic use; drug delivery systems, biodegradable; follow up studies; multi center studies; periodontitis therapy; sanguinarium chloride therapeutic use

Indexed keywords

DOXYCYCLINE; SANGUINARINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PERIODONTITIS; RANDOMIZED CONTROLLED TRIAL;

EID: 0030932203     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1997.68.2.110     Document Type: Article

References (23)

1. Dunn RL, Tipton AJ, Harkrader RJ, et al. Pharmokinetics of a biodegradable subgingival delivery system for sanguinarine. J Dent Res 1991;70(Spec. Issue):323(Abstr. 466).
2. Poison AM, Stoller NH, Hanes PJ, et al. Two multi-center trials assessing the clinical efficacy of 5% sanguinarine in a biodegradable drug delivery system. J Clin Periodontol 1996;23:782-788.
3. Title 21, Code of Federal Regulations, Part 56: Institutional Review Boards. US Government Printing Office; 1995.
4. Title 21, Code of Federal Regulations, Part 50: Institutional Review Boards. US Government Printing Office; 1995.
5. Poison AM, Southard GL, Dunn RL, et al. Periodontal pocket treatment in beagle dogs using subgingival doxycycline from a biodegradable system I. Initial clinical responses. J Periodontol 1996;67: 1176-1184.
6. Ramfjord SP. The periodontal index (PDI). J Periodontol 1967;38: 602-610.
7. Polson AM, Southard GL, Dunn RL, Poison AP, Billen JR. Initial study of guided tissue regeneration in class II furcation defects after use of a biodegradable barrier. Int J Periodontics Restorative Dent 1995;15:43-55.
8. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
9. ICD.9.CM Fourth Edition. The International Classification of Diseases, 9th revision. Volumes 1 & 2. New York: McGraw-Hill; 1995.
10. Laster L. The effect of subsampling sites within patients. J Periodont Res 1985;20:91-96.
11. Goodson JM, Cugini MA, Kent RL, et al. Multicenter evaluation of tetracycline fiber therapy. II. Clinical response. J Periodont Res 1991;26:371-379.
12. van Steenberghe D, Bercy P, Kohl J, et al. Subgingival minocycline hydrochloride ointment in moderate to severe chronic adult periodontitis in a randomized, double-blind, vehicle-controlled, multicenter study. J Periodontol 1993;64:637-644.
13. Murayama Y, Nomura Y, Yamoaka A, et al. Local administration of minocycline for periodontitis. Double-blind, comparative study of LS-007. J Japan Assoc Periodontol 1988;30:206-222.
14. Murayama Y, Isoshima O, Kurimoto K, et al. Antibiotic therapy in crevicular regions for treatment of periodontal disease. In: Hamada S, Holt SC, McGhee JR, eds. Periodontal Disease Pathogens, vol. 29. Tokyo: Quintessence Publishing Company; 1991:393-405.
15. Minabe M, Takeuchi K, Tamura T, Hori T, Umemoto T. Subgingival administration of tetracycline on a collagen film. J Periodontol 1989;60:552-556.
16. Eckles TA, Reinhardt RA, Dyer JK, Tussing GL, Szydlowski WM, DuBous LM. Intracrevicular application of tetracycline in white petrolatum for the treatment of periodontal disease. J Clin Periodontol 1990;17:454-462.
17. Ainamo J, Ellingsen BH, Hansen BF, et al. Clinical responses to subgingival application of a metronidazole 25% gel compared to the effect of subgingival scaling in adult periodontitis. J Clin Periodontol 1992;19:723-729.
18. Yamagani H, Takamori A, Sakamoto J, Okada H. Intrapocket chemotherapy in adult periodontitis using a new controlled-release insert containing ofloxacin (PT-01). J Periodontol 1992;63:2-6.
19. Minabe M, Uematsu A, Nishijima K, et al. Application of a local drug delivery system to periodontal therapy. I. Development of collagen preparations with immobilized tetracycline. J Periodontol 1989;60:113-117.
20. Stabholz A, Soskolne WA, Friedman M, Sela MN. The use of sustained release delivery of chlorhexidine for the maintenance of periodontal pockets. J Periodontol 1991;62:429-433.
21. Newman MG, Kornman KS, Doherty FM. A 6-month multicenter evaluation of adjunctive tetracycline fiber therapy used in conjunction with scaling and root planing in maintenance patients: Clinical results. J Periodontol 1994;65:685-691.
22. Imrey PB, Chilton NW, Pihlstrom BL, et al. Proposed guidelines for American Dental Association acceptance of products for professional, non-surgical treatment of adult periodontitis. J Periodont Res 1994;29:348-360.
23. Poison AM, Garrett S, Stoller NH, et al. Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. II. Clinical results. J Periodontol 1997;68:119-126.